UGenome Blog
Could Genetic Biomarkers Transform Kidney Disease Treatment?
Marlon T. Makwara & Jayden Lee, PharmD APOL1 risk variants predict rapid CKD progression and...
How Do National Genome Projects Advance the Power of Pharmacogenomics?
Zachary S. Brooks, PhD & Muunda Mudenda, M.S. Countries around the world push to create...
Pharmacogenomics Can Ease Burden On Doctors Treating Patients With Rare Diseases
This is an excerpt of Jura Health's Chris Moore and UGenome's Zachary Brooks Thought Leadership...
UGenome AI and Jeeva Clinical Trials Partner to Power Faster, Smarter Precision‑Medicine Studies
Integrated genomics pre‑screening + modular CTMS aims to cut screen‑failures and accelerate...
Pharmacogenomics: Transforming Pain Management Through Precision Medicine
Emma Louis, B.S. & Komal Sharma, MS, MBA Pharmacogenomics: Transforming Pain Management...
UGenome AI Announces Partnership with 1928 Diagnostics to Make Genomic Medicine Meaningful
for immediate release TUCSON, A.Z. – UGenome AI, a pioneer in genomic platforms to fuel...
Pharmacodynamics
Pharmacodynamics (PD) is the study of how a drug affects an organism physiologically and...
PGx Software
A tool that uses a person's genetic information to help determine which medications and doses are...
Next-Generation Sequencing (NGS)
also known as massively parallel sequencing; technologies for sequencing DNA that became available...
Haplotype
A haplotype is a set of DNA variations (polymorphisms, like SNPs and indels) on a chromosome that...
Drug Response
all the effects of a drug on an individual in relation to effectiveness, side effects, and adverse...